A modified ELISA accurately measures secretion of high molecular weight hyaluronan (HA) by graves' disease orbital cells

Endocrinology

Volumn 155, Issue 2, 2014, Pages 627-634

  Krieger, Christine C ^a   Gershengorn, Marvin C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY M22; HYALURONIC ACID; INTERLEUKIN 1BETA; POLYMER; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MIGRATION; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR WEIGHT; ORBITAL FIBROBLAST; PRIORITY JOURNAL; PROADIPOCYTE; SIGNAL TRANSDUCTION;

ADIPOCYTES; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GRAVES DISEASE; HUMANS; HYALURONIC ACID; INTERLEUKIN-1BETA; RECEPTORS, THYROTROPIN;

EID: 84893160227     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1890     Document Type: Article

References (37)

1. Iyer S, Bahn R. Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor. Best Pract Res Clin Endocrinol Metab. 2012;26: 281-289.
2. Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology. 1984;91: 1411-1419.
3. Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol. 2011;46: 155-163.
4. Lu S, Guan Q, Liu Y, et al. Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis. 2012;11:17.
5. Lu M, Lin RY. TSH stimulates adipogenesis in mouse embryonic stem cells. J Endocrinol. 2008;196: 159-169.
6. Zhang L, Grennan-Jones F, Lane C, Rees DA, Dayan CM, Ludgate M. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy. J Clin Endocrinol Metab. 2012;97: 653-662.
7. Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M. Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci. 2006;47: 5197-5203.
8. ValyaseviRW,Erickson DZ, Harteneck DA, et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab. 1999;84: 2557-2562.
9. Zhang L, Bowen T, Grennan-Jones F, et al. Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem. 2009;284: 26447-26455.
10. van Zeijl CJ, Fliers E, van Koppen CJ, et al. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. Thyroid. 2010;20: 535-544.
11. van Zeijl CJ, Fliers E, van Koppen CJ, et al. Thyrotropin receptorstimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways. Thyroid. 2011;21: 169-176.
12. Kumar S, Iyer S, Bauer H, Coenen M, Bahn RS. A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody. J Clin Endocrinol Metab. 2012;97: 1681-1687.
13. van Steensel L, Hooijkaas H, Paridaens D, et al. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients. J Clin Endocrinol Metab. 2012; 97:E944-E953.
14. Imai Y, Ibaraki K, Odajima R, Shishiba Y. Analysis of proteoglycan synthesis by retro-ocular tissue fibroblasts under the influence of interleukin 1β and transforming growth factor-β. Eur J Endocrinol. 1994;131: 630-638.
15. Kaback LA, Smith TJ. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1β in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 1999;84: 4079-4084.
16. He H, Li W, Tseng DY, et al. Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-α-inhibitor (HC*HA) purified from extracts of human amniotic membrane. J Biol Chem. 2009;284: 20136-20146.
17. Kikuchi T, Yamada H, Fujikawa K. Effects of high molecular weight hyaluronan on the distribution and movement of proteoglycan around chondrocytes cultured in alginate beads. Osteoarthritis Cartilage. 2001;9: 351-356.
18. Shiedlin A, Bigelow R, Christopher W, et al. Evaluation of hyaluronan from different sources: Streptococcus zooepidemicus, rooster comb, bovine vitreous, and human umbilical cord. Biomacromolecules. 2004;5: 2122-2127.
19. Swann DA. Studies on hyaluronic acid. I. The preparation and properties of roostercombhyaluronic acid. Biochim Biophys Acta. 1968; 156: 17-30.
20. Kawakami M, Suzuki K, Matsuki Y, et al. Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1 β but inhibited by transforming growth factor β 1. Ann Rheum Dis. 1998;57: 602-605.
21. Campo GM, Avenoso A, D'Ascola A, et al. The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis. J Cell Biochem. 2012;113: 1852-1867.
22. Jenkins RH, Thomas GJ, Williams JD, Steadman R. Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover. J Biol Chem. 2004;279: 41453-41460.
23. Webber J, Jenkins RH, Meran S, Phillips A, Steadman R. Modulation of TGFβ1-dependent myofibroblast differentiation by hyaluronan. Am J Pathol. 2009;175: 148-160.
24. Haserodt S, Aytekin M, Dweik RA. A comparison of the sensitivity, specificity, and molecular weight accuracy of three different commercially available Hyaluronan ELISA-like assays. Glycobiology. 2011;21: 175-183.
25. Neumann S, Pope A, Geras-Raaka E, Raaka BM, Bahn RS, Gershengorn MC. A drug-like antagonist inhibits thyrotropin receptormediated stimulation of cAMP production in Graves' orbital fibroblasts. Thyroid. 2012;22: 839-843.
26. Neumann S, Eliseeva E, McCoy JG, et al. A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor. J Clin Endocrinol Metab. 2011;96: 548-554.
27. Tsui S, Naik V, Hoa N, et al. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol. 2008;181: 4397-4405.
28. Hwang CJ, Afifiyan N, Sand D, et al. Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci. 2009;50: 2262-2268.
29. Smith TJ, Bahn RS, Gorman CA. Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts. J Clin Endocrinol Metab. 1989;69: 1019-1023.
30. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF.TSH-Rexpression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf). 2003;58: 280-287.
31. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab. 1998;83: 998-1002.
32. Stadlmayr W, Spitzweg C, Bichlmair AM, Heufelder AE. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Thyroid. 1997;7: 3-12.
33. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid. 1993;3: 297-300.
34. Agretti P, De Marco G, De Servi M, et al. Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroidassociated ophthalmopathy (TAO) after adipocytic differentiation. Eur J Endocrinol. 2005;152: 777-784.
35. Kumar S, Coenen MJ, Scherer PE, Bahn RS. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. J Clin Endocrinol Metab. 2004;89: 930-935.
36. Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M. Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol. 2003;30: 369-380.
37. Turcu AF, Kumar S, Neumann S, et al. A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy. J Clin Endocrinol Metab. 2013;98: 2153-2159.